Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back
Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

Improved Travel With Coronavirus Testing

Reduce the risk of facing restrictions and quarantine measures at your destination with SARS-CoV-2 pre-flight testing at Frankfurt Airport

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

International Gaucher Day 2020

International Gaucher Day 2020

We want to shine a spotlight on the incredible people in the Gaucher community. Join the art competition and tell your story here!

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Customer Feedback

Give feedback

Newsletter subscription

CAMBRIDGE, Mass. und ROSTOCK und BERLIN, Deutschland, 20. Oktober 2020 -

Centogene N.V. (Nasdaq: CNTG), ein weltweit führendes Unternehmen, welches...

Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 19, 2020 (GLOBE NEWSWIRE) -

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Weiterlesen

CAMBRIDGE, Mass., ROSTOCK und BERLIN, Deutschland, 19. Oktober 2020 -

Centogene N.V. (Nasdaq: CNTG), ein wirtschaftliches Unternehmen, das auf die...

Weiterlesen

CAMBRIDGE, Mass. und ROSTOCK und BERLIN, Deutschland und BAARN, die Niederlande, 15. Oktober 2020

Centogene N.V. (Nasdaq: CNTG), ein wirtschaftliches...

Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, and BAARN, the Netherlands, October 14, 2020 (GLOBE NEWSWIRE)

Centogene N.V. (Nasdaq: CNTG), a...

Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, September 28, 2020 (Globe Newswire)

  • Company awarded ISO 27001 Accreditation for its Information Security...
Weiterlesen

CAMBRIDGE, Mass., ROSTOCK und BERLIN, Deutschland, 28. September, 2020

  • Unternehmen erhält ISO 27001-Akkreditierung für sein Information Security Management...
Weiterlesen